Guggenheim Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.6M | Buy |
416,657
+203
| +0% | +$26.7K | 0.33% | 51 |
|
|
2026
Q1 | $58M | Sell |
416,454
-101,335
| -20% | -$14.2M | 0.45% | 37 |
|
|
2025
Q4 | $63.6M | Sell |
517,789
-11,074
| -2% | -$1.35M | 0.46% | 35 |
|
|
2025
Q3 | $58.7M | Sell |
528,863
-32,074
| -6% | -$3.65M | 0.43% | 40 |
|
|
2025
Q2 | $62.2M | Buy |
560,937
+29,713
| +6% | +$3.16M | 0.49% | 34 |
|
|
2025
Q1 | $59.5M | Sell |
531,224
-116,029
| -18% | -$12M | 0.55% | 30 |
|
|
2024
Q4 | $59.8M | Sell |
647,253
-34,237
| -5% | -$3.08M | 0.48% | 36 |
|
|
2024
Q3 | $57.1M | Sell |
681,490
-96,423
| -12% | -$7.36M | 0.4% | 42 |
|
|
2024
Q2 | $53.4M | Buy |
777,913
+82,014
| +12% | +$5.47M | 0.38% | 42 |
|
|
2024
Q1 | $51M | Sell |
695,899
-64,504
| -8% | -$4.96M | 0.36% | 48 |
|
|
2023
Q4 | $61.6M | Sell |
760,403
-6,377
| -0.8% | -$496K | 0.47% | 32 |
|
|
2023
Q3 | $57.5M | Sell |
766,780
-24,449
| -3% | -$1.88M | 0.49% | 27 |
|
|
2023
Q2 | $61M | Buy |
791,229
+19,324
| +3% | +$1.54M | 0.48% | 26 |
|
|
2023
Q1 | $64M | Sell |
771,905
-31,537
| -4% | -$2.61M | 0.54% | 19 |
|
|
2022
Q4 | $69M | Sell |
803,442
-45,064
| -5% | -$3.57M | 0.61% | 14 |
|
|
2022
Q3 | $52.3M | Sell |
848,506
-36,335
| -4% | -$2.29M | 0.48% | 23 |
|
|
2022
Q2 | $54.7M | Sell |
884,841
-14,520
| -2% | -$899K | 0.43% | 30 |
|
|
2022
Q1 | $53.5M | Sell |
899,361
-11,224
| -1% | -$717K | 0.32% | 47 |
|
|
2021
Q4 | $66.1M | Buy |
910,585
+94,509
| +12% | +$6.51M | 0.34% | 43 |
|
|
2021
Q3 | $57M | Sell |
816,076
-16,528
| -2% | -$1.16M | 0.34% | 45 |
|
|
2021
Q2 | $57.3M | Buy |
832,604
+34,046
| +4% | +$2.27M | 0.34% | 43 |
|
|
2021
Q1 | $51.6M | Sell |
798,558
-11,830
| -1% | -$763K | 0.34% | 44 |
|
|
2020
Q4 | $47.2M | Buy |
810,388
+13,870
| +2% | +$837K | 0.3% | 50 |
|
|
2020
Q3 | $50.3M | Sell |
796,518
-55,968
| -7% | -$3.88M | 0.36% | 37 |
|
|
2020
Q2 | $65.6M | Buy |
852,486
+83,442
| +11% | +$6.39M | 0.51% | 19 |
|
|
2020
Q1 | $57.5M | Sell |
769,044
-148,927
| -16% | -$10.3M | 0.58% | 13 |
|
|
2019
Q4 | $59.6M | Buy |
917,971
+78,152
| +9% | +$5.09M | 0.45% | 25 |
|
|
2019
Q3 | $53.2M | Buy |
839,819
+20,618
| +3% | +$1.35M | 0.43% | 26 |
|
|
2019
Q2 | $55.3M | Sell |
819,201
-25,861
| -3% | -$1.7M | 0.45% | 25 |
|
|
2019
Q1 | $54.9M | Buy |
845,062
+127,220
| +18% | +$8.46M | 0.45% | 23 |
|
|
2018
Q4 | $44.9M | Sell |
717,842
-17,764
| -2% | -$1.24M | 0.38% | 30 |
|
|
2018
Q3 | $56.8M | Sell |
735,606
-49,280
| -6% | -$3.72M | 0.37% | 25 |
|
|
2018
Q2 | $55.6M | Sell |
784,886
-615,961
| -44% | -$43.5M | 0.37% | 25 |
|
|
2018
Q1 | $106M | Sell |
1,400,847
-97,546
| -7% | -$7.75M | 0.26% | 39 |
|
|
2017
Q4 | $107M | Buy |
1,498,393
+3,175
| +0.2% | +$241K | 0.25% | 38 |
|
|
2017
Q3 | $121M | Sell |
1,495,218
-258,314
| -15% | -$19.8M | 0.28% | 24 |
|
|
2017
Q2 | $124M | Buy |
1,753,532
+241,544
| +16% | +$16.1M | 0.33% | 16 |
|
|
2017
Q1 | $103M | Sell |
1,511,988
-33,115
| -2% | -$2.33M | 0.28% | 27 |
|
|
2016
Q4 | $111M | Sell |
1,545,103
-55,332
| -3% | -$4.11M | 0.32% | 19 |
|
|
2016
Q3 | $127M | Buy |
1,600,435
+78,189
| +5% | +$6.35M | 0.39% | 7 |
|
|
2016
Q2 | $127M | Sell |
1,522,246
-10,453
| -0.7% | -$928K | 0.4% | 9 |
|
|
2016
Q1 | $141M | Sell |
1,532,699
-262,155
| -15% | -$23.6M | 0.44% | 6 |
|
|
2015
Q4 | $182M | Sell |
1,794,854
-128,191
| -7% | -$13.3M | 0.53% | 5 |
|
|
2015
Q3 | $189M | Sell |
1,923,045
-185,382
| -9% | -$20.6M | 0.58% | 5 |
|
|
2015
Q2 | $247M | Sell |
2,108,427
-130,227
| -6% | -$14.2M | 0.61% | 5 |
|
|
2015
Q1 | $220M | Buy |
2,238,654
+416,360
| +23% | +$42.3M | 0.52% | 6 |
|
|
2014
Q4 | $172M | Sell |
1,822,294
-25,840
| -1% | -$2.67M | 0.43% | 6 |
|
|
2014
Q3 | $197M | Sell |
1,848,134
-90,860
| -5% | -$8.9M | 0.47% | 9 |
|
|
2014
Q2 | $161M | Sell |
1,938,994
-57,827
| -3% | -$4.5M | 0.41% | 9 |
|
|
2014
Q1 | $141M | Buy |
1,996,821
+378,893
| +23% | +$29.7M | 0.4% | 8 |
|
|
2013
Q4 | $122M | Sell |
1,617,928
-45,179
| -3% | -$3.15M | 0.37% | 10 |
|
|
2013
Q3 | $105M | Buy |
1,663,107
+220,060
| +15% | +$13.2M | 0.38% | 11 |
|
|
2013
Q2 | $73.9M | Buy |
+1,443,047
| New | +$75.2M | 0.31% | 22 |
|
Other funds holding GILD
Guggenheim Capital's GILD Position: Q2 2026 in Review
Guggenheim Capital increased its Gilead Sciences (GILD) stake by 0.05% in Q2 2026, buying an estimated $26.7K and bringing the position to 416,657 shares worth $52.6M. The position accounts for 0.33% of the portfolio, ranked #51.
Guggenheim Capital first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $247M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Guggenheim Capital held 416,657 shares of Gilead Sciences worth $52.6M as of Q2 2026.
- Guggenheim Capital bought 203 Gilead Sciences shares in Q2 2026, an estimated $26.7K.
- Gilead Sciences made up 0.33% of Guggenheim Capital's portfolio in Q2 2026, its #51 holding.
- Guggenheim Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Gilead Sciences position peaked at $247M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.